The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
S-100 protein and neuron-specific enolase in cerebrospinal fluid and serum: markers of cell damage in human central nervous system.
Open accessAbstract
The development of a radioimmunoassay for S-100 protein is described. This method was used in combination with a recently developed radioimmunoassay for neuron-specific enolase in cerebrospinal fluid and serum from 47 patients with cerebral infarction, transient ischemic attack, intracerebral hemorrhage, subarachnoid hemorrhage, and head injury. In cerebrospinal fluid, increased concentrations of both S-100 and neuron-specific enolase were found after large infarcts, whereas after small infarcts and transient ischemic attacks, only neuron-specific enolase increased. The increased concentrations of S-100 and/or neuron-specific enolase were noted 18 hours to 4 days after cerebral infarction and transient ischemic attacks. Cerebrospinal fluid concentrations of these proteins also reflected the severity of the disease in patients with intracerebral hematoma, subarachnoid hemorrhage, or head injury. Temporal changes in serum S-100 and neuron-specific enolase concentrations reflected the clinical course in 4 patients. In stroke patients, the S-100 and neuron-specific enolase concentrations may reflect the extent of brain damage and could be useful in selecting patients with major stroke for more aggressive treatment during the acute phase.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4
LAEMMLI, U. K. (1970) · Nature · doi:10.1038/227680a0 · Cited by 249,961
Towbin, H., Staehelin, T., & Gordon, J. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.9.4350 · Cited by 53,385
THE PREPARATION OF 131I-LABELLED HUMAN GROWTH HORMONE OF HIGH SPECIFIC RADIOACTIVITY
GREENWOOD, F., HUNTER, W., & GLOVER, J. (1963) · Biochemical Journal · doi:10.1042/bj0890114 · Cited by 10,152
ASSESSMENT OF OUTCOME AFTER SEVERE BRAIN DAMAGE A Practical Scale
JENNETT, B. (1975) · The Lancet · doi:10.1016/s0140-6736(75)92830-5 · Cited by 7,501
A soluble protein characteristic of the nervous system
Moore, B. W. (1965) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(65)90320-7 · Cited by 1,695
NEURON-SPECIFIC ENOLASE IS PRODUCED BY NEUROENDOCRINE TUMOURS
Tapia, F. J., Barbosa, A. J. A., Marangos, P. J., Polak, J. M., Bloom, S. R., Dermody, C., & Pearse, A. G. E. (1981) · The Lancet · doi:10.1016/s0140-6736(81)92682-9 · Cited by 458
Carney, D. N., Ihde, D. C., Cohen, M. H., Marangos, P., Bunn, P. A., Minna, J. D., & Gazdar, A. F. (1982) · The Lancet · doi:10.1016/s0140-6736(82)91748-2 · Cited by 382
Marangos, P. J., Schmechel, D., Parma, A. M., Clark, R. L., & Goodwin, F. K. (1979) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1979.tb11735.x · Cited by 223
S100a0 (αα) Protein Is Present in Neurons of the Central and Peripheral Nervous System
Isobe, T., Takahashi, K., & Okuyama, T. (1984) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1984.tb05415.x · Cited by 155
Mokuno, K., Kato, K., Kawai, K., Matsuoka, Y., Yanagi, T., & SOBUE, I. (1983) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(83)90155-7 · Cited by 141
Cited by
Plasma MicroRNAs as Sensitive and Specific Biomarkers of Tissue Injury
Laterza, O. F., Lim, L., Garrett-Engele, P. W., Vlasakova, K., Muniappa, N., Tanaka, W. K., Johnson, J. M., Sina, J. F., Fare, T. L., Sistare, F. D., et al. (2009) · Clinical Chemistry · doi:10.1373/clinchem.2009.131797 · Cited by 619
S100B in brain damage and neurodegeneration
Rothermundt, M., Peters, M., Prehn, J. H. M., & Arolt, V. (2003) · Microscopy Research and Technique · doi:10.1002/jemt.10303 · Cited by 609
Dayon, L., Hainard, A., Licker, V., Turck, N., Kuhn, K., Hochstrasser, D. F., Burkhard, P. R., & Sanchez, J.-C. (2008) · Analytical Chemistry · doi:10.1021/ac702422x · Cited by 561
Neurobehavioural sequelae of cardiopulmonary b ypass
Selnes, O. A., Goldsborough, M. A., Borowicz, L. M., & McKhann, G. M. (1999) · The Lancet · doi:10.1016/s0140-6736(98)07576-x · Cited by 502
Missler, U., Wiesmann, M., Friedrich, C., & Kaps, M. (1997) · Stroke · doi:10.1161/01.str.28.10.1956 · Cited by 456
Glial and neuronal proteins in serum predict outcome after severe traumatic brain injury
Vos, P. E., Lamers, K. J. B., Hendriks, J. C. M., van Haaren, M., Beems, T., Zimmerman, C., van Geel, W., de Reus, H., Biert, J., & Verbeek, M. M. (2004) · Neurology · doi:10.1212/01.wnl.0000120550.00643.dc · Cited by 412
Changes in Ca2+-binding proteins in human neurodegenerative disorders
Heizmann, C. W., & Braun, K. (1992) · Trends in Neurosciences · doi:10.1016/0166-2236(92)90067-i · Cited by 409
Chemical monitoring of neurosurgical intensive care patients using intracerebral microdialysis
Persson, L., & Hillered, L. (1992) · Journal of Neurosurgery · doi:10.3171/jns.1992.76.1.0072 · Cited by 391
Self-citationGFAP Versus S100B in Serum after Traumatic Brain Injury: Relationship to Brain Damage and Outcome
Pelinka, L. E., Kroepfl, A., Leixnering, M., Buchinger, W., Raabe, A., & Redl, H. R. (2004) · Journal of Neurotrauma · doi:10.1089/0897715042441846 · Cited by 389
Tang, Y., Xu, H., Du, X. L., Lit, L., Walker, W., Lu, A., Ran, R., Gregg, J. P., Reilly, M., Pancioli, A., et al. (2006) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600264 · Cited by 326
Serum S100β: A noninvasive marker of blood‐brain barrier function and brain lesions
Kanner, A. A., Marchi, N., Fazio, V., Mayberg, M. R., Koltz, M. T., Siomin, V., Stevens, G. H. J., Masaryk, T., Ayumar, B., Vogelbaum, M. A., et al. (2003) · Cancer · doi:10.1002/cncr.11409 · Cited by 269
Nilotinib Effects in Parkinson’s disease and Dementia with Lewy bodies
Pagan, F., Hebron, M., Valadez, E. H., Torres-Yaghi, Y., Huang, X., Mills, R. R., Wilmarth, B. M., Howard, H., Dunn, C., Carlson, A., et al. (2016) · Journal of Parkinson’s Disease · doi:10.3233/jpd-160867 · Cited by 265
S-100 Protein: Serum Marker of Focal Brain Damage After Ischemic Territorial MCA Infarction
Büttner, T., Weyers, S., Postert, T., Sprengelmeyer, R., & Kuhn, W. (1997) · Stroke · doi:10.1161/01.str.28.10.1961 · Cited by 259
A sensitive ELISA for glial fibrillary acidic protein: application in CSF of adults
Rosengren, L. E., Wikkelsø, C., & Hagberg, L. (1994) · Journal of Neuroscience Methods · doi:10.1016/0165-0270(94)90011-6 · Cited by 256
Stroke Biomarkers: Progress and Challenges for Diagnosis, Prognosis, Differentiation, and Treatment
Saenger, A. K., & Christenson, R. H. (2010) · Clinical Chemistry · doi:10.1373/clinchem.2009.133801 · Cited by 252
Benedict, C., Cedernaes, J., Giedraitis, V., Nilsson, E. K., Hogenkamp, P. S., Vågesjö, E., Massena, S., Pettersson, U., Christoffersson, G., Phillipson, M., et al. (2014) · Sleep · doi:10.5665/sleep.3336 · Cited by 86
Cerebrospinal fluid apolipoprotein E concentration decreases after traumatic brain injury
Kay, A. D., Petzold, A., Kerr, M., Keir, G., Thompson, E. J., & Nicoll, J. A. R. (2003) · Journal of Neurotrauma · doi:10.1089/089771503321532824 · Cited by 33
Metadata
- Authors
- Persson, L., Hårdemark, H. G., Gustafsson, J., Rundström, G., Mendel-Hartvig, I., Esscher, T., & Påhlman, S.
- Venue
- Stroke
- Published
- 1987-09
- Volume
- 18
- Issue
- 5
- Pages
- 911-918
- ISSN
- 0039-2499 (ISSN-L)
- 1524-4628
- OpenAlex
- W2021576901
- Cited by
- 486
- References
- 18
- FWCI
- 1.19
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.